Celluma POD Series 2: The World's First 4-in-1 Handheld Medical LED
Portable. Cordless. Clinically Proven. Discover the medical-grade hardware reshaping professional light therapy into a handheld powerhouse.
Celluma Light Therapy, the global leader in professional-grade LED technology, has officially announced the launch of the Celluma POD Series 2. This launch represents a significant biophysical milestone: the integration of four distinct medical indications into a single, pocket-sized device.
The POD Series 2 is the first and only handheld, battery-powered LED device globally registered as a Class II Medical Device and FDA-cleared for four key therapeutic outcomes: Acne Clearance, Skin Rejuvenation, Pain Management, and Body Contouring.
Four FDA-Cleared Treatment Modes
The POD Series 2 utilises 38 medical-grade LEDs to deliver professional-grade photon density across a 106.5 cm² treatment area. Each mode targets a specific biological chromophore with a clinically calibrated wavelength.
Technical Performance Data
What separates the POD 2 from consumer-grade “beauty pens” is its power density and uniform energy distribution. It is engineered to deliver the exact joules required to reach the biostimulatory threshold for each indication.
| FDA Clearances4 indications — Acne, Skin Rejuvenation, Pain Management, Body Contouring |
| LED Architecture38 Medical-Grade Polychromatic LEDs across 106.5 cm² treatment area |
| Wavelengths465nm (Blue) · 640nm (Red) · 635nm + 880nm (Body & Pain) |
| Power DeliverySustained rechargeable battery — fully cordless operation |
| Hands-Free UseAdjustable compression strap included for zero-gap contact without manual holding |
| Device ClassFDA Class II Medical Device — not a cosmetic beauty gadget |
“The new POD 2 is another example of what sets Celluma apart. By delivering four FDA-cleared treatments in an affordable, battery-powered form, we're changing the way people experience light therapy as part of their integrative health regimens.”
— Curtis Cluff, CEO of CellumaFrequently Asked Questions
The Celluma POD Series 2 is FDA-cleared for four specific indications: Acne (465nm blue — targets P. acnes bacteria), Skin Rejuvenation (640nm red — collagen synthesis via fibroblast activation), Pain Management (880nm near-infrared — deep inflammation and joint pain), and Body Contouring (circumferential reduction of waist and thighs). It is the world's only handheld battery-powered device with all four clearances.
Yes. The POD Series 2 features a high-capacity internal rechargeable battery for complete cordless operation — making it the ideal travel device for maintaining clinical skincare and pain recovery protocols anywhere. No power cable or wall outlet required during sessions.
Yes. Every POD Series 2 includes an adjustable compression strap. This allows you to secure the device to a joint, the face, or any target area for a consistent hands-free 30-minute session — unlike standard handheld devices that require manual contact throughout.
The POD 2 uses the same medical-grade wavelengths (465nm, 640nm, 880nm) as Celluma's full-size clinical panels. The difference is treatment area — the POD covers 106.5 cm² per session for targeted applications, versus the full-face and body coverage of the PRO or HOME II. The POD is ideal for precision treatment of specific joints, facial zones, or contour areas.
The Celluma POD Series 2 is available in Singapore through Celluma Asia, the authorised regional distributor. Free island-wide delivery is available. WhatsApp +65 9446 8877 to check current stock and pricing.
The POD Series 2 delivers three clinically calibrated wavelengths across its 38 LEDs: 465nm blue for acne (photodynamic bacterial destruction), 640nm red for skin rejuvenation (fibroblast activation and collagen synthesis), and 880nm near-infrared for pain and body contouring (deep tissue penetration, inflammation reduction, and lipid mobilisation). All wavelengths are factory-calibrated to medical-grade precision.



Leave a comment
Trang web này được bảo vệ bằng hCaptcha. Ngoài ra, cũng áp dụng Chính sách quyền riêng tư và Điều khoản dịch vụ của hCaptcha.